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Summary: Plasma aldosterone, 18-hydroxycorticosterone, corticosterone, 18-hydroxydeoxycorticosterone, and
deoxycorticosterone were determined in 15 healthy male volunteers (34 ± 2 years) following the inhibition of con-
verting enzyme with captopril (SQ 14.225), either with or without indometacin pretreatment. These studies were
performed with the aid of a radioimmunological method for the simultaneous determination of the steroids from
1.0 ml of plasma. The procedure involves one extraction and one Chromatographie step. Highly sensitive and specific
rabbit antisera were raised for all steroids. Precision and accuracy are shown to be equivalent to those of single steroid
radioimmunoassays. Without indometacin pretreatment a constant and significant fall in aldosterone and 18-hydroxy-
corticosterone plasma levels was obtained after captopril. 18-Hydroxydeoxycorticosterone and corticosterone did not
change after inhibition of converting enzyme. Under indometacin pretreatment all basal steroid levels were significantly
reduced. After captopril, aldosterone did not change and 18-hydroxycorticosterone showed a smaller decrease than
without indometacin. 18-Hydroxydeoxycorticosterone and corticosterone increased significantly \1A hour after
captopril. We conclude that indometacin significantly reduces basal mineralocorticoid production of adrenal zona
glomerulosa and fasciculata. Furthermore, the effect of captopril on aldosterone and 18-hydroxycorticosterone is
abolished or diminished by inhibition of prostaglandin biosynthesis, but indometacin does not prevent an augmented
secretion of 18-hydroxydeoxycorticosterone and corticosterone.
Simultaner Radioimmunassay für Aldosteron und seine Vorstufen: Konzentrationen im Plasma des Menschen
nach Hemmung des Converting Enzyme vor und nach Blockade der Prostaglandinbiosynthese
Zusammenfassung: Aldosteron, 18-Hydroxycorticosteron, Corticosteron, 18-Hydroxydesoxycorticosteron und Des-
oxycorticosteron wurden im Plasma von 15 gesunden männlichen Probanden (34 ± 2 Jahre) nach oraler Gabe des
Converting Enzyme-Inhibitors Captopril (SQ 14.225) bestimmt. Die Untersuchungen sind vor und nach einer Vorbe-
handlung mit Indometacin durchgeführt worden. Es wird ein Radioimmunoassay beschrieben, mit dem die genannten
Steroide simultan aus l rrd Plasma bestimmt werden können. Gegen alle Steroide konnten hoch sensitive und spezi-
fische Antiseren erzeugt werden. Die Präzision und Richtigkeit der Methode ist vergleichbar mit Radioimmunoassays,
in denen nur ein Steroid bestimmt wird. Ohne Vorbehandlung mit Indometacin wurde nach Gabe von Captopril ein
konstanter und signifikanter Abfall des Aldosteron und des 18-Hydroxycorticosteron im Plasma beobachtet. 18-
Hydroxydesoxycorticosteron und Corticosteron änderten sich nicht nach Captopril. Nach Vorbehandlung mit Indo-
metacin waren alle basalen Steroidkonzentrationen signifikant erniedrigt. Auf Gabe von Captopril hin änderte sich
die Aldosteronkonzentratiori nicht und 18-Hydroxycorticosteron fiel geringer ab als ohne Vorbehandlung mit Indo-
metacin. 18-Hydroxydesojcycprticosteron und Corticosteron stiegen unter Indometacin U4 Stunden nach Captopril
signifikaiit an. Die Ergebnisse zeigen, daß Indometacin die basale Mineralocorticoidsekretion der Zona glomerulosa
und fasciculata supprimiert. Weiterhin wird der Effekt von Captopril auf die Aldosteron- und 18-Hydroxycortico-
steronkonzentration durch die vorherige Gabe von Indometacin aufgehoben bzw. reduziert. Die Vorbehandlung mit
Indometacin kann jedoch eine gesteigerte Freisetzung von 18-Hydroxydesoxycorticosteron und Corticosteron nicht
verhindern.
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Introduction
Hie role of prostaglandins in the regulation of aldo-
sterone2) secretion is not clearly defined. It is known
that corticotropin stimulates the adrenocortical prosta-
glandin system which, on the other hand, has been pro-
posed to mediate corticotropin induced steroido-
genesis (1-3). Furthermore, studies with intact animals
have suggested that the prostaglandin system modulates
the angiotensin II stimulated aldosterone production
(4). However, recent attempts failed to enhance directly
the aldosterone secretion by different prostaglandin
metabolites in vitro (5, 6). The effect of the inhibition
of the prostaglandin system on the main precursur
steroids of aldosterone has not yet been evaluated in man.
Plasma levels of these steroids both with and without
inhibition of prostaglandin biosynthesis may provide
further knowledge about regulation of aldosterone.
We developed a radioimmunoassay for simultaneous
measurement of aldosterone, 18-hydroxycorticosterone,
corticosterone, and deoxycorticosterone. Studies were
performed in healthy men under basal conditions and
after inhibition of converting enzyme with captopril
(SQ 14.225; 2-0-methyl-3-mercaptopropanoyl-L-
proline), with and without the blockade of the prosta-
glandin system. It could be shown that all basal steroid
levels were significantly suppressed by indometacin
pretreatment. Furthermore, inhibition of prostaglandin
biosynthesis by indometacin pretreatment altered the




[1,2-3H] 18-hydroxy-ll-deoxy corticosterone (specific radio-
activity: 1.8 TBq/mmol, 51 Ci/mmol; 1000 counts/min = 2.8 pg),
[l,2(n)-JH] 18-hydroxycorticosterone (1.1 TBq/mmol, 32 Ci/
mmol, 1000 counts/min = 7.4 pg), [l,2(n)-3H]ll-deoxycortico-
2) The following trivial names are used:





















sterone (1.2 TBq/mmol, 35 Ci/mmol; 1000 counts/min = 5.0 pg)
and [1,2,6,7(nKÇ]aldosterone (3.7 TBq/mmol, 102 Ci/mmol;
1000 counts/min = 2.2 pg) were purchased from Amersham
Buchler, Braunschweig. [ 1,2,6,7 (n>3 H ] corticosterone (3.0 TBq/
mmol, 82.1 Ci/mmol; 1000 counts/min = 3.5 pg) was obtained
from NEN, Langen (FRG). All radioactive chemicals were puri-
fied by thin layer chromatography before analysis.
Pharmaceuticals
Captopril (INN) (SQ 14.225; 2-O-methyl-3-mercaptopropanoyl-
Æ,-proline) was kindly supplied as an investigational drug by
Dr. R. K. Liedke (E. R. Squibb, von Heyden GmbH, Regensburg,
FRG). Indometacin (INN): Amuno®, Sharp & Dohme GmbH,
M nchen, FRG.
Chemicals and other materials
Non-radioactive steroids were purchased either from Merck,
Darmstadt (FRG), Makor, Jerusalem (Israel), or Steraloids>
Wilton N. H. (USA), and were stored in a desiccator before
use. Tris-buffer (tris(hydroxymethyl)aminomethane), acetic
acid 0.96 kg/1, benzene, dichloromethane, ethanol, isooctane,
and methanol were obtained from Merck. All solvents were
highly purified. Human ̂ globulin (Beriglobin®) and FreuncTs
adjuvant were obtained from Behring, Marburg (FRG), charcoal
(Norit A) from Serva, Heidelberg (FRG) and dextran from Fluka,
Neu Ulm (FRG).
Buffer solution was 0.05 mol/1 Tris buffer pH 8 (adjusted with
acetic acid) and human ^globulin 0.1 g/1. Charcoal-dextran
solution consisted of 3 g/1 charcoal and 1.2 g/1 dextran suspended
in Tris-buffer. Antisera were raised in female New Zealand white
rabbits (mean age: 6 months, mean body weight: 1.2 kg).
Preparation of antigens
Antigens were synthesized according the procedure described
by Erlanger (7).
Immunisation
The first injection consisted of 3 mg of the respective antigen
dissolved in a mixture of 0.5 ml isotonic saline and 0.5 mg
complete Freund's adjuvant. The following injections con-
sisted of 1 mg antigen in the same mixture and were carried
out during the first three weeks at 8 day intervals, then in
three weekly intervals for the subsequent booster-injections.
One half of the antigen was injected intramuscularly and the
other intradermally 10-15 times. Five animals were immunised
for each antigen in parallel. Antisera titre was calculated as the
dilution of antiserum which bound a fraction of 0.5 of the
tested radioactive antigen.
Specifity
Cross reactions of the different steroids were estimated according
to the method described by Abraham (8). Procedures were per-
formed under assay conditions. Only biologically active Ci9 and
Cji steroids were tested.
Affinity constant
The standard curves of the different antisera were analysed
mathematically according to the method described by Nisonoff
(9) and Scatchard (10).
Extraction of plasma samples
Amounts of each steroid corresponding to 8000 counts/min dis^
solved in a total volume of 50 ìÀ methanol were added as internal
standards to 1 ml of plasma. Plasma was extracted with 40 ml ice-
cold dichloromethane in a rotating shaker after an equilibration
period of 15 min. The aqueous and the organic phase were separ-
ated and", thereafter, dichloromethane was evaporated to dryness
under a gentle stream of nitrogen.
Chromatography
Descending paper chromatography was performed in closed tanks.
For simultaneous separation of the spectrum of steroids by one
Chromatographie step the system isooctane benzene methanol
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H2O = 60 ml + 140 mi + 120 ml + 80 ml was used. Evaluation of
the procedure is described in detail elsewhere (11).
Assay procedures
All incubations were prepared in 500 ì\ volumes. 500 ìÀ dextran-
coated charcoal suspension was added to incubations for separ-
ating bound and free radioactivity. Only those antisera of the
five steroid antigens were used which showed the highest titre
at the end of the immunisation procedure. Standard curves and
cross reaction analyses were performed for all steroids in buffer
solution with 100 ìÀ diluted antiserum, 100 ìÀ of the respective
radioactive steroid, 100 ì\ non-radioactive steroid, and 200 ìÀ as
volume substitution. For standard curves of deoxycorticosterone
200 ìÀ buffer were replaced by 200 ìÀ eluate from a pure paper
strip to compensate for contingent unspecific blanks that might
be introduced in radioimmunoassay tubes by the paper eluate
containing the unknown steroid. Sensitivity analyses of deoxy-
corticosterone were performed in buffer solution. Preincubation
was at 20 °C for 30 min with gently shaking. Incubation was at
4 °C for 24 hours.
Radioimmunoassay of aldosterone, 18-hydroxy corticosterone,
18-hydroxydeoxycorticosterone and deoxycorticosterone
(unknown samples)
After eluting the respective bands from the paper strips with
10 ml methanol, the evaporated methanol specimens were
dissolved in 1 ml buffer for 1 hour. 300 ìÀ were taken for
recovery analyses. 300 ìÀ were pipetted in duplicate into radio-
immunoassay tubes, together with 100 ìÀ 7-globulin buffer
(containing 1000 counts/min radioactive steroid) and 100 ìÀ
diluted antiserum.
Radioimmunoassay of corticosterone (unknown samples)
The respective band from the paper strip was eluted with 10 ml
methanol. The methanol was evaporated and the residue dis-
solved in 2 ml buffer for 1 hour. 500 ìÀ were taken for recovery
analyses. 50 ìÀ were pipetted in duplicate into tubes, to which
the following solutions were added: 100 ìÀ 7-globulin buffer
(containing 2000 counts/min radioactive steroid), 250ì1 ã-globu^
lin buffer (volume substitution), and 100 ìÀ diluted antiserum.
Quality^control of radioimmunoassay
For quality control purposes, two 1 ml samples .of plasma from
patients with bilateral adrenalectomia ("0-plasma") and two
1 ml of pool-plasma ("standard-plasma") were analysed in the
same way as unknown samples in each radioimmunoassay.
Studies in human volunteers
15 healthy male volunteers aged 24 to 47 (mean 34 ± 2) years
were included in the study and were fully informed of the ex^·
perimental nature and the potential risks of the investigational
drug. Written informed consent was obtained. Subjects were
investigated under ambulatory conditions and ad libitum diet
between 8 a.m. and 1 p.m. Studies were performed in active
orthostasis. Blood pressure (random zero sphygmomanometer)
and heart rate were recorded twice in the sitting position (2 min
rest) befpre the oral ingestion of 100 mg captopril and Vfc, 1, VA,
and 3Vz hours thereafter. Excretion of sodium and potassium was
measured in the urine samples collected for 90 min before and
for 90 min after captopril. Venous blood was drawn before,
and H, 1*4, and 31/? hours after captopril. Samples were collected
in heparinized tubes and were centrifuged immediately. Plasma
was stored at 20 9C The same protocol was performed again
14 days later under prostaglandin blockade with 200 mg indo-
metacin (50 mg, respectively, at 1 a.m., 6 a.m., and at 9.30
aurii. together with captopril).
Statistical analyses
Values are mean ± S.D. for methodological values and mean
± S.E.M. for experimental results. Linear regression analyses
and Student's tatest were used for statistical evaluation,
Results
Evaluation of the method
Antisera
Kinetic data of the antisera are listed in table 1. Those
animals were evaluated which showed the highest titre
levels of the different antigens at the end of the immuni-
sation procedure. The standard curves of the antisera
(n = 10 for each steroid) showed a statistically signi-
ficant difference between 0 and 3 pg (B0/T ± S.D.) for
all antisera: 18-hydroxycorticosterone, aldosterone,
corticosterone and deoxycorticosterone (p < 0.01).
Thus, 3 pg of each steroid could be distinguished from
zero by the respective antisera (sensitivity). All antisera
were tested against at least 12 biologically relevant
steroids (specificity). Cross-reactivity of the different
antisera are shown in table 2.
Extraction and chromatography
The following radioactivity recovery rates for the five
steroids were obtained after extraction and chromato-
graphy (n = 10): 18-hydroxycorticosterone 39 ± 7, aldo-
sterone 37 ± 7, 18-hydroxydeoxycorticosterone 38 ± 5,
corticosterone 40 ± 6, and deoxycorticosterone 50 ± 8%.
Assay parameters
Precision
Within assay variation was determined from ten replicate
measurements in the same assay of samples from a
plasma pool (intraassay). The following values were found
(coefficient of variation in parenthesis): 18-hydroxy-
corticosterone 231 ± 29 (12.5%), aldosterone 146 ± 13
(8.9%), 18-hydroxydeoxycorticosterone 112 ± 11 (9.8%)
and deoxycorticosterone 196 ± 21 ng/1 (10.7%); cortico-
sterone 5.04 ± 0.37 Mg/1 (7.3%). Between assay variation
was evaluated from samples of the same plasma pool
determined in five different assays (interassay): 18-
hydroxycorticosterone 258 ± 38 (14.7%), aldosterone
137 ± 15 (10.9%), 18-hydroxydeoxycorticosterone
Tab. 1. Comparison of kinetic data of the used antisera.
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128 ± 15 (11.7%) and deoxycorticosterone 201 ± 28
ng/1 (13.9%); corticosterone 4.99 ± 0.47 ìg/l (9.4%).
Accuracy
To test the accuracy of the multi-steroid assay, known
quantities of unlabelled steroids were added to 1 ml of
pool plasma taken from patients wi iAddison's diseases.
Samples were examined by replicate analyses of each
point (n = 10). Increasing amounts of steroids were added
in physiological concentrations. In figure 1 measured
steroid concentrations are plotted against the amounts
of steroid added to the plasma.
Blanks
Assay blanks were evaluated from 1 ml plasma of a bi-
laterally adrenalectomized patient and were included in
all procedures of the assay (n = 10): aldosterone 7 ± 3,
18-hydroxycorticosterone 8 ± 5,18-hydroxydeoxy-
corticosterone 6 ± 3 ng/1, and corticosterone 0.11 ± 0.04
Mg/l. For deoxycorticosterone an assay blank of 42 ± 13
ng/1 steroid-free plasma was found.
Paper blanks were tested by replacing buffer solution
with equal amounts of paper eluate in all tubes of the
standard curves (fig. 2). In the paper eluate curve of
corticosterone, bound radioactivity of all points was
slightly higher than in the normal standard curve ("nega-
tive blank")· Bound radioactivity in the deoxycortico-
sterone standard curve was higher than in the paper
eluate curve which is consistent with a paper blank of
about 10 pg for all points determined.
Practicability
During five working days a skillful technician can deter-
mine the five different steroids in 25 plasma samples,
which represents 125 steroid values per week. Calcula-
tion of the standard curves and the plasma samples is
performed by electronic data processing (spline).
Experimental protocol
Response to captopril without indometacin pretreatment
Heart rate before captopril ingestion was 76 ± 2 min'1
and remained constant during the investigation. Mean
arterial blood pressure fell continuously from the basal
value before captopril treatment (97 ± 3) to a minimum
1 hour thereafter (87 ± 2 mmHg; ñ < 0.02) and then in-
creased again to pretreatment levels 31Ë hours after capto-
pril. Basal sodium (206 ± 23) and potassium (107 ± 14
ìðéïÀ/ôçßç) excretion remained unchanged after capto-
pril. A continuous arid significant decrease of aldosterone
and 18-hydroxydeoxycorticosterone was found after
inhibition of converting enzyme. 18-Hydroxydeoxy-
corticosterone and corticosterone, however, remained
unchanged (fig. 3). Basal deoxycorticosterone level was
171 ±9 ng/1.
Response to captopril under indometacin pretreatment
All values for heart rate (basal 70 ± 2 min"1) were signi-
ficantly (p < 0.05) and constantly lower than those with-
out indometacin pretreatment. Mean basal blood pressure
on indometacin (97 ± 3) was unchanged in comparison
with the control. However, the decrease of blood pressure
1 hour°after captopril (93 ± 2 mmHg) was significantly
smaller (p < 0.05) than in the experiment without indo-
metacin pretreatment. Basal sodium (201 ± 28) and
potassium (103 ± 13 ìðéïÀ/ðûç) excretion rates under
indometacin remained unchanged before and after capto-
pril.
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r s coefficient of correlation.
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All control steroid levels in active prthostasis were signi-
ficantly lower under prostaglandin biosynthesis inhibi-
tion. Basal deoxycorticosterone level was 1 19 ± 28 ng/1
(p < 0.05). Aldosterone did not change after captopril.
l&Hydroxy corticosterone remained constant Vi hour
after captopril but showed a significant decrease 1 ia and
316 hours after converting enzyme inhibition. However,
18-hydroxydeoxycorticosterone and corticosterone
levels increased significantly 1J4 hour after captopril
(fig. 3).
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Fig. 2. Standard curves of the spectrum of steroid antisera under normal conditions (closed circles) compared with standard curves in
which buffer solution was replaced by paper eluate (open circles).
Discussion
A highly specific and sensitive radioimmunoassay is
described for aldosterone and its precursors 18-hydroxy-
corticosterone, corticosterone, deoxycorticosterone and
18-hydroxydeoxycprticosterone from 1 ml plasma. The
obvious advantage of the presented method is that very
low concentrated steroids can be simultaneously
estimated from a minute amount of human plasma by
a simplified procedure. Specificity of the evaluated anti-
sera was assessed by testing biologically relevant cross-
reacting corticosteroids. Cross^reactions were compar-
able with data recently reported (12—15). No gross
cross-reactivity was detected in any of the antisera.
Sensitivity of the different standard curves allows the
measurement of very small amounts of the respective
steroid. The calculated affinity constants of the anti-
sera are comparable to values recently reported (14,
16,17). Recovery rates after extraction and chfomato-
graphy were in the range of 40-50% for the spectrum
of mineralocorticoids. This high yield was achieved by
using only one extraction- and one chromajpgraphic
step.
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Fig. 3. Concentrations of plasma aldosterone, 1 8-hydroxycorti-
costerone, 18-hydroxydeoxy corticosterone, and corti-
costerone before, 30, 90, and 210 min after captopril.
Determinations were performed both without (· — ·)
and under (o — ̂ o) indometacin pretreatment.
a) p < 0.05, b) p < 0.01, and c) p < 0.005 vs. respective
control level.
1) p < 0.05 and 2) p < 0.01 vs. without indometacin.
Preparation and determination of 18-hydroxylated
mineraloeorticoids are difficult because of their known
instability in acidified solutions (18, 19). In order to
avoid formation of various compounds by reactions
with the 18-hydtQxyl-group, we therefore used highly
purified .organic solvents without any traces of acids
(Uvasol®) and all buffer solutions were alkaline (pH 8).
So far, paper chromatography guarantees the most care-
ful handling of 184iydroxylated steroids compared with
other Chromatographie methods (e.g. thin layer or
column chromatography with silica gel)- in this context
exposure to organic solvents is shortened by the de-
scribed assay. In recently published multiple assays at
least two extractions and Chromatographie separations
were necessary before radioimmunoassay (20—22).
For aldosterone, 18-hydroxycorticosterone, 18-hydroxy-
deoxycorticosterone, and corticosterone no relevant
assay blanks could be detected. The blanks evaluated
from plasma of a patient with bilateral adrenalectomy
were found to be below the sensitivity of the respective
standard curves. This was consistent with the result,
that no paper blanks of those steroids could be demon-
strated. The deoxycorticosterone assay blank of about
40 ng/1 was mainly due to the paper blank of this steroid,
which covered the complete standard curve. Several
attempts failed to eliminate or reduce the paper blank
of this assay. Blank-free conditions could only be esta-
blished by displacing buffer solution with paper eluate
for constructing the standard curve (23). By this mani-
pulation, the assay sensitivity of deoxycorticosterone
was considerably reduced.
Standard curves of our assay were evaluated with a small
amount of tracer (2000 counts/min). Depending on the
specific radioactivity of the different steroids, the quan-
tity added to the antigen in the respective radioimmuno-
assay tube varied from a minimal 4.4 pg (aldosterone) to
a maximal 14.8 pg (18-hydroxycorticosterone). This is
of great importance with respect to the low concentra-
tions of steroids (mean plasma concentration: 50—200
ng/1). Assays for these steroids were so constructed that
tracer amounts used for recovery analyses of samples
after extraction and chromatography could partly be
taken for radioimmunoassay (about 1000 counts/min
for 40% total recovery). Therefore only 1000 counts/
min must be added to assay tubes to fit the 2000
counts/min of the standard curves (24). The methodo-
logical procedure needs a very careful and accurate
handling of all samples to provide constant recovery
rates.
Studies in human volunteers
Studies were performed in normotensive volunteers
under ambulatory conditions (active orthostasis) with-
out any instructions for diet in the sodium replete
state * Captopril induced a sustained fall in aldosterone
(25) and 18-hydroxycorticosterone without indometacin
pretreatment. Corticosterone and 18-hydroxydeoxycorti-
costerone remained unchanged after captopril. Inhibition
of the conversion of angiotensin I to angiotensin II by
captopril is the most probable reason for the fall in
aldosterone and 18-hydroxycorticosterone. This may
support the hypothesis that aldosterone and 18-hydroxy-
corticosterone are more sensitive to changes of angio-
tensin II levels than corticosterone and 18-hydroxyde-
oxycorticosterone which are mainly regulated by cortico-
tropin (21, 26). The inhibition of prostaglandin biosyn-
thesis by indometacin was accompanied by a significant
decrease of all control steroid levels during active ortho-
stasis, which may be due to the inhibition of the adreno-
cortical prostaglandin system. On the other hand, intra-
renal prostaglandins stimulate renin release (27). Inhibi-
tion of renal prostaglandin formation reduces renin
secretion, which results in diminished basal angiotensin
II plasma levels under indometacin.
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This mechanism, in addition, may further decrease aldo-
sterone and 18-hydroxycorticosterone levels. Basal
plasma levels of aldosterone and 18-hydroxycorticoster-
one under control conditions were greatly reduced by
indometacin, and no or only a smaller decrease was
found after captopril without indometacin pretreatment.
Under inhibition of prostaglandin biosynthesis a signi-
ficant increase of corticosterone and 18-hydroxydeoxy-
corticosterone was found l J4 hour after captopril. The
reason for this behaviour remained unresolved. Two
possible mechanisms should be discussed:
(1) Since corticosterone and 18-hydroxydeoxycortico-
sterone are mainly regulated by corticotropin, an
augmented corticotropin secretion could be responsible:
Under indometacin, vasodilating vascular prostaglandins
are diminished, thus resulting in an increased peripheral
vascular resistance (28). Maintenance of control blood
pressure was achieved by a compensatory reduction of
heart rate. In this labile haemodynamic equilibrium the
application of the blood pressure lowering drug, capto-
pril, may be a prominent stress stimulus for the organ-
ism, which might consequently contribute to an enhanced
corticotropin secretion;
(2) On the other hand, an elevated sensitivity arid/or
number of corticotropin receptors on zona fasciculata
cells must be considered. Recently it has been shown
that the inhibition of the prostaglandin system effected
an increase of/3-adrenoreceptots on human leukocyte
membranes (29). A similar mechanism for cortico-
tropin receptors on the level of zona fasculata cells
could explain our findings.
The data of OUT experiments suggest that inhibition
of adrenocortical prostaglandm biosynthesis by indo-
metacin decreased all basal steroid levels, but could
not prevent an augmented secretion of corticosterone
and 18-hydroxydeoxy corticosterone after captopril
administration.
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